Medicare Enrolled

Dr. Andrew Norato

Physician Assistant · Shenandoah, TX
Low-engagement
8845 SIX PINES DR STE 200, Shenandoah, TX 77380
2814405300
In practice since 2019 (6 years)
NPI: 1023655628 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Norato from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Norato? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Norato

Dr. Andrew Norato is a physician assistant in Shenandoah, TX, with 6 years of NPI registration.

Between the years covered by Open Payments, Dr. Norato received a total of $5,098 from 34 pharmaceutical and/or device companies across 148 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Norato is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 6 years in practice $5,098 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$5,098
Total received (2021-2024)
Avg $1,274/year across 4 years
Top 9% in TX for physician assistant
34
Companies
148
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,098 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,873
2023
$1,091
2022
$1,527
2021
$607

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,472
Novo Nordisk Inc
$536
Lilly USA, LLC
$515
ABBVIE INC.
$374
Boehringer Ingelheim Pharmaceuticals, Inc.
$281
Amgen Inc.
$228
Bayer Healthcare Pharmaceuticals Inc.
$200
Bayer HealthCare Pharmaceuticals Inc.
$169
Genentech USA, Inc.
$164
Dexcom, Inc.
$142
Biohaven Pharmaceutical Holding Company Ltd.
$136
Axsome Therapeutics, Inc.
$135
Pharmacyclics LLC, an AbbVie Company
$125
GlaxoSmithKline, LLC.
$109
AbbVie Inc.
$56
Nevro Corp.
$50
Horizon Therapeutics plc
$44
PFIZER INC.
$38
Exact Sciences Corporation
$36
Edwards Lifesciences Corporation
$29
PhotoniCare Inc
$27
Phadia US Inc.
$23
Allergan, Inc.
$22
Servier Pharmaceuticals LLC
$22
Janssen Biotech, Inc.
$20
Rigel Pharmaceuticals, Inc.
$20
Regeneron Healthcare Solutions, Inc.
$18
180 Medical, Inc.
$17
Astellas Pharma US Inc
$15
Ipsen Biopharmaceuticals, Inc
$15
Kowa Pharmaceuticals America, Inc.
$15
Azurity Pharmaceuticals, Inc.
$15
Olympus America Inc.
$15
IDORSIA PHARMACEUTICALS US INC
$14
Top 3 companies account for 49.5% of total payments
Associated products mentioned in payments ›
ABRYSVO · AIRSUPRA · Alecensa · Auvelity · BREZTRI · CREON · Cologuard Collection Kit · DEXCOM G7 GSS (161) · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ERLEADA · EVENITY · FARXIGA · GENTLECATH · IMBRUVICA · ImmunoCAP · JARDIANCE · KRYSTEXXA · Kerendia · LIBTAYO · LINZESS · LUPRON DEPOT · Livalo · MOUNJARO · NURTEC ODT · Otezla · OtoSight Middle Ear Scope · Ozempic · PREVNAR 20 · QULIPTA · QUVIVIQ · Rybelsus · SHINGRIX · SOMATULINE DEPOT · SYNTHROID · Senza · TECENTRIQ · TIBSOVO · TRELEGY ELLIPTA · TRULICITY · Tavalisse · UBRELVY · VRAYLAR · Wegovy · Xtandi · ZEPBOUND · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for physician assistant in TX.

Looking for a physician assistant in Shenandoah?
Compare physician assistants in the Shenandoah area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician assistants within 10 mi
530
Per 100K population
81.0
County median income
$97,266
Nearest hospital
HOUSTON METHODIST THE WOODLANDS HOSPITAL
4.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Norato is a physician assistant, with low-engagement industry engagement in the top 9% of TX peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Norato receive payments from pharmaceutical companies?
Yes. Dr. Norato received a total of $5,098 from 34 companies across 148 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Norato) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →